What is GeneLink, Inc. (GNLKQ) stock price today?

GeneLink, Inc. (GNLKQ) is currently trading at $0.00.

What is GNLKQ P/E ratio?

GeneLink, Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is GNLKQ return on equity (ROE)?

GeneLink, Inc.'s return on equity (ROE) is 100.00%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is GeneLink, Inc.'s market cap?

GeneLink, Inc. has a market capitalization of $10601.

OTC · Biotechnology

GeneLink, Inc. (GNLKQ) Stock

$0.00 OTC: GNLKQ Healthcare

GeneLink, Inc. specializes in delivering 12-gene DNA profiling services.

Valuation

Metric	Value
Price	$0.00
Market Cap	$10601
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.01
EPS (TTM)	$0.00
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	100.00%
ROA	-69.12%
ROCE	902.77%
Gross Margin	19.40%
Operating Margin	-204.69%
Net Margin	-141.05%
Debt/Equity	0.00
Current Ratio	0.34

Annual Financials (USD)

Metric	2008	2009	2010	2011	2012
Revenue	$6.0M	$9.0M	$8.0M	$5.0M	$2.0M
Operating Profit	$-2.0M	$-2.0M	$-2.0M	$-4.0M	$-3.0M
Net Profit	$-3.0M	$-3.0M	$-3.0M	$-4.0M	$-3.0M
EPS	$-0.03	$-0.03	$-0.02	$-0.02	$-0.01
Op Margin	-35.0%	-28.8%	-30.6%	-76.1%	-162.4%

Balance Sheet (USD)

Metric	2008	2009	2010	2011	2012
Total Assets	$3.0M	$2.0M	$2.0M	$3.0M	$1.0M
Total Liabilities	$2.0M	$3.0M	$3.0M	$4.0M	$4.0M
Cash	$0	$0	$0	$1.0M	$0
Borrowings	$0	$0	$0	$0	$0

Cash Flow (USD)

Metric	2008	2009	2010	2011	2012
Operating Cash Flow	$-1.0M	$-3.0M	$-1.0M	$-3.0M	$-2.0M
Investing Cash Flow	$-1.0M	$0	$0	$0	$0
Financing Cash Flow	$1.0M	$1.0M	$0	$1.0M	$0
Net Cash Flow	$-1.0M	$0	$0	$0	$-1.0M
Free Cash Flow	$-2.0M	$-3.0M	$-1.0M	$-3.0M	$-3.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	0.06
FCF Yield	-24767.22%
Quick Ratio	0.21
Interest Coverage	-10.48
Return 1Y	0.00%
Return 3Y	-60.00%
Return 5Y	—

Ownership

Insiders Held0.00%

Institutions Held0.00%

Institutions Float Held0.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BSSPBaseline Productions, Inc.	$0.00	—	-0.02	$74377	0.00%
CNBXCNBX Pharmaceuticals Inc.	$0.00	—	0.10	$9251	0.00%
ENDVEndonovo Therapeutics, Inc.	$0.00	—	1.00	$31875	0.00%
FLHLFFilament Health Corp.	$0.00	—	-1.89	$26179	0.00%
GMVDFG Medical Innovations Holdings Ltd	$0.00	—	0.00	$25992	0.00%

About GeneLink, Inc.

GeneLink, Inc. specializes in delivering 12-gene DNA profiling services. Beyond genetic analyses, the company also provides clients with bespoke nutritional supplements tailored to individual health needs. Additionally, the firm crafts a comprehensive collection of dermatological products. Established in 1994, GeneLink, Inc. maintains its headquarters in Orlando, Florida.

GeneLink, Inc. (GNLKQ) stock trades at $0.00 with a market capitalization of $10601. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.01. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, GeneLink, Inc. generates a return on equity (ROE) of 100.00% — well above the market average, a sign of a high-quality business, return on capital employed of 902.77%, an operating margin of -204.69%, a net profit margin of -141.05%.

Official website: www.genelink.com

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides